You have 9 free searches left this month | for more free features.

City

Aarhus N (1)

Carlton (1)

Dallas (1)

Erzurum (1)

Grand Rapids (1)

Greenville (1)

Sydney (1)

Teneriffe (1)

Condition

Dry Eye Disease (1)

Endometrioid Endometrial Cancer (1)

HIV I Infection (1)

Inhalation Therapy; Complications (1)

Solid Tumors, Adult (1)

Overall Status

Not yet recruiting (2)

Recruiting (2)

Completed (1)

Sign in for free

Phase

n/a (2)

phase 1/phase 2 (2)

phase 1 (1)

Sponsor

Onconova Therapeutics, Inc. (2)

Alcon Research (1)

Bionor Immuno AS (1)

Mukader Kaya (1)

Collaborator

Celgene Corporation (1)

Study Documents

Intervention Type

drug (3)

behavioral (1)

biological (1)

other (1)

Funder Type

Industry (4)

Other (1)

Study Type

Interventional (5)

ON 123300

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Endometrioid Endometrial Cancer Trial (Narazaciclib, Letrozole 2.5mg)

Not yet recruiting

Endometrioid Endometrial Cancer

Narazaciclib
Letrozole 2.5mg

(no location specified)

Feb 1, 2023

Solid Tumors, Adult Trial in Grand Rapids, Greenville, Dallas (ON123300)

Recruiting

Solid Tumors, Adult

ON123300

Grand Rapids, Michigan
+2 more

Jan 27, 2022

Dry Eye Disease Trial in Sydney, Teneriffe, Carlton (FID123300 ocular lubricant, FID123301 ocular lubricant, FID122505 ocular

Not yet recruiting

Dry Eye Disease

FID123300 ocular lubricant
+2 more

Sydney, New South Wales, Australia
+2 more

Jun 2, 2023

Inhalation Therapy; Complications Trial in Erzurum (Behavioral)

Recruiting

Inhalation Therapy; Complications

Behavioral

Erzurum, Center, Turkey

Ataturk University Faculty of Nursing

May 13, 2023

HIV I Infection Trial in Aarhus N (Romidepsin, Vacc-4x, rhuGM-CSF)

Completed

HIV I Infection

Romidepsin
+2 more

Aarhus N, Denmark

Aarhus University Hospital, Skejby Sygehus

Jan 11, 2017